We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Constellium
CSTM
$3.88B
| $5.88M | 0.01% |
+400,000
| New | +$5.74M |
|
|
PV
777
DELISTED
Primavera Capital Acquisition Corporation
PV
| $5.88M | 0.01% |
+600,000
| New | +$5.93M |
|
778
Quest Diagnostics
DGX
$26.3B
| $5.87M | 0.01% |
45,700
+37,200
| +438% | +$4.58M |
|
|
KDMN
779
DELISTED
Kadmon Holdings, Inc.
KDMN
| $5.83M | 0.01% |
1,500,000
| – | – |
|
780
BuzzFeed
BZFD
$94.1M
| $5.81M | 0.01% |
+150,000
| New | +$5.91M |
|
781
Huntsman Corp
HUN
$1.78B
| $5.77M | 0.01% |
+200,000
| New | +$5.6M |
|
782
Applied Industrial Technologies
AIT
$13.3B
| $5.72M | 0.01% |
+62,700
| New | +$5.32M |
|
783
AAR Corp
AIR
$5.89B
| $5.55M | 0.01% |
133,248
-128,955
| -49% | -$5.09M |
|
784
HF Sinclair
DINO
$14.7B
| $5.52M | 0.01% |
154,200
-3,100
| -2% | -$104K |
|
785
Element Solutions
ESI
$9.37B
| $5.49M | 0.01% |
300,000
-50,000
| -14% | -$919K |
|
|
JNPR
786
DELISTED
Juniper Networks
JNPR
| $5.44M | 0.01% |
+214,900
| New | +$5.29M |
|
|
BLU
787
DELISTED
BELLUS Health Inc.
BLU
| $5.38M | 0.01% |
+1,400,000
| New | +$5.31M |
|
788
Wabtec
WAB
$49.9B
| $5.32M | 0.01% |
67,203
-73,432
| -52% | -$5.7M |
|
789
Affirm
AFRM
$25.6B
| $5.3M | 0.01% |
+75,000
| New | +$7.29M |
|
|
IIII
790
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
| $5.3M | 0.01% |
+532,430
| New | +$5.43M |
|
791
Aramark
ARMK
$14.8B
| $5.29M | 0.01% |
+193,900
| New | +$5.32M |
|
|
HES
792
DELISTED
Hess
HES
| $5.26M | 0.01% |
74,400
-55,700
| -43% | -$3.56M |
|
793
Arq
ARQ
$90.6M
| $5.22M | 0.01% |
950,000
| – | – |
|
|
OTIC
794
DELISTED
Otonomy, Inc.
OTIC
| $5.1M | 0.01% |
2,000,500
+975,000
| +95% | +$4M |
|
|
DOCU
795
DocuSign
DOCU
$10.9B
| $5.06M | 0.01% |
+25,000
| New | +$5.8M |
|
796
Sana Biotechnology
SANA
$949M
| $5.02M | 0.01% |
+150,000
| New | +$4.88M |
|
|
BRPMU
797
DELISTED
B. Riley Principal 150 Merger Corp. Unit
BRPMU
| $5M | 0.01% |
+500,000
| New | +$5.1M |
|
|
HERAU
798
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
| $5M | 0.01% |
+500,000
| New | +$5.02M |
|
|
FCAX
799
DELISTED
Fortress Capital Acquisition Corp.
FCAX
| $4.91M | 0.01% |
+500,000
| New | +$4.93M |
|
|
TMAC
800
DELISTED
The Music Acquisition Corporation
TMAC
| $4.89M | 0.01% |
+500,000
| New | +$4.86M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.